FGEN insider buying and SEC filings, explained
Fibrogen Inc. · CIK 921299
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$54K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| May 14, 2026 | Open-market purchase Amended filing | Thane Wettig (CEO and Director) bought 2,800 shares at $7.09 ($20K) in an open-market purchase. Holdings up 11% to 27,203 shares. Not marked as a 10b5-1 plan trade. This amends a filing from May 18. | SEC filing Filed May 19, 2026 |
| Nov 13–17, 2025 | Purchase (code P) | Thane Wettig (CEO and Director) bought 3,700 shares between Nov 13, 2025 and Nov 17, 2025 at about $9.12 ($34K), reported as a purchase (code P). Holdings up 17% to 24,939 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 17, 2025 |
15 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow FGEN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.